Fermentation of resistant starches: Influence of in vitro models on colon carcinogenesis

Nutrition and Cancer

Volumn 58, Issue 1, 2007, Pages 85-92

  Fässler, Caroline ^a   Gill, Chris I R ^b   Arrigoni, Eva ^a   Rowland, Ian ^b   Amadò, Renato ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; STARCH;

ANIMAL CELL; ARTICLE; BATCH FERMENTATION; CANCER INHIBITION; CANCER MODEL; COLON CANCER; COLON CARCINOGENESIS; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; ELECTRIC RESISTANCE; GENOTOXICITY; HUMAN; HUMAN CELL; ILEOSTOMY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SUPERNATANT;

EID: 34447526648     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701308232     Document Type: Article

References (44)

1. Cummings JH and Englyst HN: Measurement of starch fermentation in the human large intestine. Can J Physiol Pharmacol 69 (1), 121-129, 1991.
2. Englyst HN, Kingman SM, Hudson GJ, and Cummings JH: Measurement of resistant starch in vitro and in vivo. Br J Nutr 75 (5), 749-755, 1996.
3. Baghurst PA, Baghurst KI, and Record SJ: Dietary fibre, non-starch polysaccharides and resistant starch: a review. Food Aust 48 S3-S35, 1996.
4. Ferguson LR, Tasman-Jones C, Englyst H, and Harris PJ: Comparative effects of three resistant starch preparations on transit time and short-chain fatty acid production in rats. Nutr Cancer 36 (2), 230-237, 2000.
5. Kleessen B, Stoof G, Proll J, Schmiedl D, Noack J, et al.: Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. J Anim Sci 75, 2453-2462, 1997.
6. Le Leu RK, Brown IL, Hu Y, and Young GP: Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium, and lumenal contents in rats. Carcinogenesis 24 (8), 1347-1352, 2003.
7. Thornton JR: High colonic pH promotes colorectal-cancer. Lancet 1 (8229), 1081-1083, 1981.
8. Nagengast FM, Hectors MPC, Buys WAM, and Vantongeren JHM: Inhibition of secondary bile acid formation in the large intestine by lactulose in healthy subjects of 2 different age groups. Eur J Clin Invest 18 (1), 56-61, 1988.
9. Summerton J, Goeting N, Trotter GA, and Taylor 1: Effect of deoxycholic acid on the tumor incidence, distribution, and receptor status of colorectal cancer in the rat model. Digestion 31 (2-3), 77-81, 1985.
10. Phillips J, Muir JG, Birkett A, Lu ZX, Jones GP, et al.: Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. Am J Clin Nutr 62 (1), 121-130, 1995.
11. Basson MD, Turowski GA, Rashid Z, Hong F, and Madri JA: Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Dig Dis Sci 41 (10), 1986-1993, 1996.
12. Hague A, Elder DJE, Hicks DJ, and Paraskeva C: Apoptosis in colorectal tumor cells - induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 60 (3), 400-406, 1995.
13. Velazquez OC, Seto RW, Choi J, Zhou DY, Breen F, et al.: Butyrate inhibits deoxycholate-induced increase in colonic mucosal DNA and protein synthesis in vivo. Dis Colon Rectum 40 (11), 1368-1375, 1997.
14. Abrahamse SL, Pool-Zobel BL, and Rechkemmer G: Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. Carcinogenesis 20 (4), 629-634, 1999.
15. Cassidy A, Bingham SA, and Cummings JH: Starch intake and colorectal cancer risk - an international comparison. Br J Cancer 69 (5), 937-942, 1994.
16. Toden S, Bird AR, Topping DL, and Conlon MA: Differential effects of dietary whey and casein on colonic DNA damage in rats. Aust J Dairy Technol 60 (2), 146-148, 2005.
17. Toden S, Bird AR, Topping DL, and Conlon MA: Resistant starch attenuates colonic DNA damage induced by higher dietary protein in rats. Nutr Cancer 51 (1), 45-51, 2005.
18. Kettlitz B, Coppin J, Röper H, and Bornet F: Highly fermentable resistant starch. United States Patent No. 6043229, 2000.
19. Lebet V, Arrigoni E, and Amadò R: Digestion procedure using mammalian enzymes to obtain substrates for in vitro fermentation studies. Lebensm-Wiss Technol 31, 509-515, 1998.
20. Minekus M, Marteau P, Havenaar R, and Huisintveld JHJ: A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA Altern Lab Anim 23 (2), 197-209, 1995.
21. Brouns F, Arrigoni E, Langkilde AM, Verkooien 1, Fässler C, et al.: Physiological and metabolic properties of a digestion-resistant maltodextrin, classified as type 3 resistant starch. J Agric Food Chem 55 (4), 1574-1581, 2007.
22. Fässler C, Arrigoni E, Venema K, Hafner V, Brouns F, et al.: Digestibility of resistant starch containing preparations using two in vitro models. Eur J Nutr DOI 10.1007/s00394-00006-00618-00397, 2006.
23. Lebet V, Arrigoni E, and Amadò R: Measurement of fermentation products and substrate disappearance during incubation of dietary fibre sources with human fecal flora. Lebensm-Wiss Technol 31, 473-479, 1998.
24. Minekus M, Smeets-Peeters M, Bernalier A, Marol-Bonnin S, Havenaar R, et al.: A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol 53 (1), 108-114, 1999.
25. Fässler C, Arrigoni E, Venema K, Brouns F, and Amadò R: In vitro fermentability of differently digested resistant starch preparations. Mol Nutr Food Res 50 (12), 1220-1228, 2006.
26. Van Nuenen MHMC, Meyer DP, and Venema K: The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Microb Ecol Health Dis 15, 137-144, 2003.
27. Venema K, van Nuenen HMC, Smeets-Peeters M, Minekus M, and Havenaar R: TNO's in vitro large intestinal model: an excellent screening tool for functional food and pharmaceutical research. Ernährung/Nutrition 24 558-564, 2000.
28. Hansen MB, Nielsen SE, and Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell-growth/cell kill. J Immunol Methods 119 (2), 203-210, 1989.
29. Mosmann T: Rapid colorimetric assay for cellular growth and survival - Application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1-2), 55-63, 1983.
30. Rieger MA, Parlesak A, Pool-Zobel BL, Rechkemmer G, and Bode C: A diet high in fat and meat but low in dietary fibre increases the genotoxic potential of 'fecal water.' Carcinogenesis 20 (12), 2311-2316, 1999.
31. Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, et al.: Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer 51 (1), 102-109, 2005.
32. Coles LT, Moughan PJ, and Darragh AJ: In vitro digestion and fermentation methods, including gas production techniques, as applied to nutritive evaluation of foods in the hindgut of humans and other simple-stomached animals. Anim Feed Sci and Tech 123, 421-444, 2005.
33. Lapre JA and Vandermeer R: Diet-induced increase of colonic bile acids stimulates lytic activity of fecal water and proliferation of colonic cells. Carcinogenesis 13 (1), 41-44, 1992.
34. Rafter JJ, Child P, Anderson AM, Alder R, Eng V, et al.: Cellular toxicity of fecal water depends on diet. Am J Clin Nutr 45 (3), 559-563, 1987.
35. Vanmunster IP, Tangerman A, Dehaan AFJ, and Nagengast FM: New Method for the Determination of the Cytotoxicity of Bile Acids and Aqueous Phase of Stool - the Effect of Calcium. Eur J Clin Invest 23 (12), 773-777, 1993.
36. Venturi M, Hambly RJ, Glinghammar B, Rafter JJ, and Rowland IR: Genotoxic activity in human fecal water and the role of bile acids: a study using the alkaline comet assay. Carcinogenesis 18 (12), 2353-2359, 1997.
37. Lin HC and Visek WJ: Large intestinal pH and ammonia in rats - Dietary fat and protein interactions. J Nutr 121 (6), 832-843, 1991.
38. Visek WJ: Diet and cell growth modulation by ammonia. Am J Clin Nutr 31 (10), S216-S220, 1978.
39. Rosignoli P, Fabiani R, De Bartolomeo A, Spinozzi F, Agea E, et al.: Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 22 (10), 1675-1680, 2001.
40. Gill CIR, Heavey P, McConville E, Bradbury I, Fässler C, et al.: Effect of fecal water on an in vitro model of colonic mucosal barrier function. Nutr Cancer 57 (1), 59-65, 2007.
41. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, et al.: Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20 (8), 1425-1431, 1999.
42. Martinez-Palomo A: Ultrastructural modifications of intercellular junctions between tumor cells. In Vitro 6 (1), 15-20, 1970.
43. Hollander D: Crohn's disease - a permeability disorder of the tight junction. Gut 29 (12), 1621-1624, 1988.
44. Hollande F, Lee DJ, Choquet A, Roche S, and Baldwin GS: Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells. J Cell Sci 116 (7), 1187-1197, 2003.